Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Unity Biotechnology Inc (UBX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Unity Biotech's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.510 +0.010    +0.67%
29/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
1.500
-0.010
-0.662%
11:40:50 - Real-time Data
  • Volume: 43,531
  • Bid/Ask: 1.420 / 1.510
  • Day's Range: 1.500 - 1.520
Type:  Equity
Market:  United States
Unity Biotech 1.510 +0.010 +0.67%

UBX User Rankings

 
This table ranks investing.com users according to the performance of their sentiments for Unity Biotech share prices.

Sign up for a free investing account and share your sentiments to see yourself on our Unity Biotechnology Inc sentiment user ranking table.
RankUsernameTotalClosedWinningWin %Chg. %
1Yann Belin111100+100%
2Chuii Flores111100+100%
3Rayme Marrero111100+18.37%
4Ido Shechter111100+5.33%
5Ramiro Marrero111100+4.88%
6Dennis Moroz111100+2.67%
7שמעון גלעד1100-0.18%
8Javier García1100-7.16%
9Jamil Lambert87457.14-8.34%
10Semanur Gul1100-9.46%
11владимир рад1100-11.91%
12Eduardo TeixeiraDaSilva1100-11.95%
13Brage Børtnes1100-14.49%
14Giovanni Magnin1100-17.16%
15Simo Laraki1100-18.89%
16Хомяк Обыкновенный1100-100%
17nikhil kothari1100-100%
18Nick LaRue1100-100%
19Sergiy Chernoshchokov1100-100%
20Brandon Joshua1100-100%
21Billy Sarris1100-100%
22Reggie Pinder1100-100%
23Kasper Tusindfryd1100-100%
24Eduardo TeixeiraDaSilva1100-100%
25Devin Heaphy1100-100%
26דב גרצמן33133.33-109.19%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UBX Price Commentary

Write your thoughts about Unity Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Taner Kaplankiran
Taner Kaplankiran Nov 28, 2019 9:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 the company raised another $55 million in 2018 (for $210 million in total funding) before going public just a couple of months later in May with a pre-IPO valuation of $712 million. Currently, its market cap sits at about a third of that. Unity targets senescent cells (sometimes referred to as zombie cells), which are cells that have stopped dividing but accumulate in tissues and organs, causing inflammation and other problems as we age. The company is in a phase 2 clinical trial with a drug candidate to treat osteoarthritis of the knee. The study is expected to enroll approximately 180 patients with initiation expected in the fourth quarter of 2019 and initial 12-week results expected in the second half of 2020.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email